CLRB - Cellectar Biosciences Inc. (CLRB) Q1 2024 Earnings Call Transcript

2024-05-14 13:05:17 ET

Cellectar Biosciences, Inc. (CLRB)

Q1 2024 Earnings Conference Call

May 14, 2024, 08:30 AM ET

Company Participants

James Caruso - President and Chief Executive Officer

Andrei Shustov - Senior Vice President, Medical

Jarrod Longcor - Chief Operating Officer

Shane Lea - Chief Commercial Officer

Chad Kolean - Chief Financial Officer

Conference Call Participants

Ahu Demir - Ladenburg Thalmann

Jeff Jones - Oppenheimer

Jonathan Aschoff - ROTH MKM

Presentation

Operator

Good morning and welcome to Cellectar Biosciences First Quarter 2024 Earnings Call. Today's call is being recorded.

Before we begin, I would like to remind everyone that statements made during this call relating to Cellectar’s expected future performance, future business prospects or future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. Although the company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions. Actual outcomes and results are subject to risks and uncertainties that could differ materially believe from those forecasts due to the impact of many factors beyond the control of Cellectar.

The company assumes no obligation to update or supplements any forward-looking statements whether as a result of new information, future events or otherwise. Participants are directed to the cautionary notes set forth in today's press release, which is available on the Investor Relations portion of the company's website, as well as the risk factors set forth in Cellectar’s annual reports filed with the SEC for factors that could cause actual results to differ materially from those anticipated in the forward-looking statements.

At this time, I would like to turn the call over to Jim Caruso, President and Chief Executive Officer of Cellectar. Mr. Caruso, please go ahead....

For further details see: